|
Press Release
NFκB Reporter 293, NIH3T3, C2C12 Stable Cell Lines
Redwood City, Calif. October 2005รข??Panomics, Inc. expands its popular NFκB Reporter Stable Cell Lines in three new cell lines: 293, NIH3T3, and C2C12.
About Panomics, Inc.
Panomics is a privately-held life science company focused on parallel quantitative biology (PQB) a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. Panomics has grown rapidly on the value of QuantiGene and QuantiGene Plex, our proprietary bDNA technology for gene expression analysis in cell-based assays, as well as our signal transduction and transcription factor assays. The company recently launched Deliver X a new siRNA delivery reagent for non-cytotoxic transfection of RNAi reagents into primary cell lines, the first in a series of biomolecule delivery products. Panomics (formerly Genospectra) was founded in 2000 and is based in Fremont, CA. For further information, log on to www.panomics.com.
|
